HistCite - node 2918: Oxidative damage of DNA by chromium(V) complexes: relative importance of base versus sugar oxidation

2918 View: Overview

Author(s)	Bose RN; Moghaddas S; Mazzer PA; Dudones LP; Joudah L; Stroup D
Title	Oxidative damage of DNA by chromium(V) complexes: relative importance of base versus sugar oxidation
Source	NUCLEIC ACIDS RESEARCH 27(10):2219-2226
Date	1999 MAY 15
Type	Journal : Article
LCR: 14 NCR: 71 LCS: 3 GCS: 18
Comment
Address	Kent State Univ, Dept Chem, Kent, OH 44242 USA. NE Ohio Univ, Coll Med, Dept Biochem, Rootstown, OH 44272 USA.
Reprint	Bose, RN, Kent State Univ, Dept Chem, Kent, OH 44242 USA.
Abstract	Chromium(V)-mediated oxidative damage of deoxyribonucleic acids was investigated at neutral pH in aqueous solution by utilizing bis(2-ethyl-2-hydroxybutanato)oxochromate(V) (I) and bis(hydroxyethyl)amino-tris(hydroxymethyl)methane)oxochromate(V) (II). Single-stranded and double-stranded (ds) calf thymus and human placenta DNA, as well as two oligomers, 5'-GATCTAGTAGGAGGACAAATAGTGTPTG-3' and 5'- GATCCAAGCAAACACTATTTGTCCTCCTACTA-3', were reacted with the chromium(V) complexes. Most products were separated and characterized by chromatographic and spectroscopic methods, Polyacrylamide gel electrophoresis experiments reveal more damage at G sites in comparison to other bases. Three primary oxidation products, 5-methylene-2-furanone (5-MF), furfural and 8-oxo-2'-deoxyguanosine, were characterized, A minor product, which appears to be thymine propenal, was also observed. The dsDNA produces more furfural than furanone, The formation of these two products resulted from hydrogen abstraction dr hydride transfer from C1' and C5' positions of the ribose to the oxo-chromium(V) center. Since no enhancements of these products (except propenal) were observed in the presence of oxygen, mechanisms pertaining to the participation of activated oxygen species may be ruled out. The oxidation of the G base is most likely associated with an oxygen atom transfer from the oxo-metallates to the double bond between C8 and N7 of the purine ring. The formation of the propenal may be associated with an oxygen-activated species, since a marginal enhancement of this product was observed in the presence of oxygen, The formation of furfural in higher abundance over 5-MF for dsDNA was attributed to the ease of hydrogen abstraction (or hydride transfer) from the C5' compared to C1' position of the ribose within a Cr(V)-DNA intermediate in which the metal center is bound to the phosphate diester moiety.
CR	AJMERA S, 1986, BIOCHEMISTRY-US, V25, P6586 ALAJLOUNI A, 1994, INORG CHEM, V33, P1014 ARKIN MR, 1997, CHEM BIOL, V4, P389 BLOMMAERT FA, 1995, BIOCHEMISTRY-US, V34, P8474 BOSE RN, 1989, ACS NAT M DALL TX BOSE RN, 1992, INORG CHEM, V31, P1987 BOSE RN, 1996, J AM CHEM SOC, V118, P7139 BOSE RN, 1998, NUCLEIC ACIDS RES, V26, P1588 CADET J, 1986, BIOCHIMIE, V68, P813 CHEN X, 1992, J AM CHEM SOC, V114, P322 CHEN XY, 1991, J AM CHEM SOC, V113, P5884 CHENG CC, 1995, J AM CHEM SOC, V117, P2970 CHUNG MH, 1992, BIOCHEM BIOPH RES CO, V88, P1 COHEN MD, 1993, CRIT REV TOXICOL, V23, P255 CONNETT PH, 1983, STRUCT BOND, V54, P93 CULLIS PM, 1996, J AM CHEM SOC, V118, P2775 DEFLORA S, 1990, MUTAT RES, V238, P99 DEVASAGAYAM TPA, 1991, BIOCHEMISTRY-US, V30, P6283 DICKMAN MH, 1994, CHEM REV, V94, P569 DIZDAROGLU M, 1991, FREE RADICAL BIO MED, V10, P225 DODDRIDGE ZA, 1998, J AM CHEM SOC, V120, P10998 DUFF RJ, 1993, J AM CHEM SOC, V115, P3350 EASOM KA, 1988, INORG CHEM, V27, P2331 EASTMAN A, 1986, BIOCHEMISTRY-US, V25, P3912 ENTERLINE PE, 1974, J OCCUP MED, V16, P523 EPE B, 1991, CHEM-BIOL INTERACT, V80, P239 FLOYD RA, 1986, FREE RADICAL RES COM, V1, P163 FONKENG BS, 1995, J CHEM SOC DALT 1221, P4129 FONKENG BS, 1998, J INORG BIOCHEM, V72, P163 GARRISON JM, 1989, J AM CHEM SOC, V111, P191 GASMI G, 1991, NUCLEIC ACIDS RES, V19, P2835 GOODGAME DML, 1986, J INORG BIOCHEM, V26, P219 GOODGAME DML, 1987, INORG CHIM A-BIOINOR, V135, P115 HECHT SM, 1986, ACCOUNTS CHEM RES, V19, P383 HOUSE DA, 1965, NATURE, V208, P776 HOUSE DA, 1966, INORG CHEM, V6, P1077 KANE SA, 1995, J AM CHEM SOC, V117, P9107 KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137 KASAI H, 1992, J AM CHEM SOC, V114, P9692 KINO K, 1998, J AM CHEM SOC, V120, P7373 KORTENKAMP A, 1996, ANN CLIN LAB SCI, V26, P160 KORTENKAMP A, 1996, ARCH BIOCHEM BIOPHYS, V329, P199 KRUMPOLC M, 1979, J AM CHEM SOC, V101, P3206 LAY PA, 1998, J AM CHEM SOC, V120, P6704 LEONARD A, 1975, BR J IND MED, V32, P62 LUO H, 1996, ANN CLIN LAB SCI, V26, P185 LUO H, 1996, J INORG BIOCHEM, V64, P25 MAXAM AM, 1980, METHOD ENZYMOL, V65, P499 NATARAJAN A, 1994, MOL ASPECTS ANTICANC, V2, P197 NEYHART GA, 1995, J AM CHEM SOC, V117, P1463 OBRIEN P, 1989, INORG CHIM ACTA, V161, P261 POGOZELSKI WK, 1998, CHEM REV, V98, P1089 PRATVIEL G, 1991, NUCLEIC ACIDS RES, V19, P6283 PRATVIEL G, 1995, ANGEW CHEM INT EDIT, V34, P746 SAMSEL EG, 1985, J AM CHEM SOC, V107, P7606 SCOTT SL, 1992, J AM CHEM SOC, V114, P4205 SEIDEL CAM, 1996, J PHYS CHEM-US, V100, P5541 SHEU C, 1993, J AM CHEM SOC, V115, P10446 SHEU C, 1995, J AM CHEM SOC, V117, P6439 SHI XL, 1988, BIOCHEM BIOPH RES CO, V156, P137 SHI XL, 1989, BIOCHEM BIOPH RES CO, V163, P627 SIGMAN DS, 1986, ACCOUNTS CHEM RES, V19, P180 STANDEVEN AM, 1991, PHARMACOL TOXICOL, V68, P449 STEARNS DM, 1983, STRUCT BOND, V54, P93 STEARNS DM, 1995, BIOCHEMISTRY-US, V34, P910 STEENKEN S, 1989, CHEM REV, V89, P503 STEENKEN S, 1997, J AM CHEM SOC, V119, P617 STEMP EDA, 1997, J AM CHEM SOC, V119, P2921 SUGDEN KD, 1996, J AM CHEM SOC, V118, P10811 SUGIYAMA H, 1993, J AM CHEM SOC, V115, P4443 SUGIYAMA M, 1986, CANCER RES, V46, P4547